Transcriptomic profiling of tumor microenvironment reveals distinct immune subgroups of metastatic melanoma and its potential implications for immunotherapy

Yixuan Huang; Peng Zhang

doi:10.1016/j.jgg.2021.03.008

Volume 48 Issue 5

May 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2021 > 48(5): 426-428

PDF( 1088 KB)

Transcriptomic profiling of tumor microenvironment reveals distinct immune subgroups of metastatic melanoma and its potential implications for immunotherapy

doi: 10.1016/j.jgg.2021.03.008

Division of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA

Received Date: 2020-11-09
Publish Date: 2021-05-20

Abstract

FullText(HTML)

References(18)

References

Aran, D., Hu, Z., Butte, A.J., 2017. xCell:digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220.

Becht, E., Giraldo, N.A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W.H., et al., 2016. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218.

Chen, Y.-P., Wang, Y.-Q., Lv, J.-W., Li, Y.-Q., Chua, M.L.K., Le, Q.-T., Lee, N., Colevas, A.D., Seiwert, T., Hayes, D.N., et al., 2019. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma:implications for immunotherapy. Ann. Oncol. 30, 68-75.

Edwards, J., Wilmott, J.S., Madore, J., Gide, T.N., Quek, C., Tasker, A., Ferguson, A., Chen, J., Hewavisenti, R., Hersey, P., et al., 2018. CD103⁺ tumor-resident CD8⁺ T cells are associated with improved survival in immunotherapy-naïve melanoma patients and expand significantly during anti-PD-1 treatment. Clin. Canc. Res. 24, 3036-3045.

Johnson, D.B., Sosman, J.A., 2015. Therapeutic advances and treatment options in metastatic melanoma. JAMA Oncol. 1, 380-386.

Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J.S., Li, B., Liu, X.S., 2017. TIMER:a web server for comprehensive analysis of tumor-infiltrating immune cells. Canc. Res. 77, e108ee110.

Luke, J.J., Flaherty, K.T., Ribas, A., Long, G.V., 2017. Targeted agents and immunotherapies:optimizing outcomes in melanoma. Nat. Rev. Clin. Oncol. 14, 463-482.

Li, H., van der Leun, A.M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A.C.J., van den Braber, M., Rozeman, E.A., Haanen, J.B.A.G., Blank, C.U., et al., 2019. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176, 775-789. e18.

Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., Hoang, C.D., Diehn, M., Alizadeh, A.A., 2015. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453-457.

O'Donnell, J.S., Teng, M.W.L., Smyth, M.J., 2019. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151-167.

Sade-Feldman, M., Yizhak, K., Bjorgaard, S.L., Ray, J.P., de Boer, C.G., Jenkins, R.W., Lieb, D.J., Chen, J.H., Frederick, D.T., et al., 2018. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998-1013. e20.

Sharma, P., Hu-Lieskovan, S., Wargo, J.A., Ribas, A., 2017. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707-723.

Sia, D., Jiao, Y., Martinez-Quetglas, I., Kuchuk, O., Villacorta-Martin, C., Castro de Moura, M., Putra, J., Camprecios, G., Bassaganyas, L., Akers, N., et al., 2017. Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology 153, 812-826.

Tirosh, I., Izar, B., Prakadan, S.M., Wadsworth, M.H. 2nd, Treacy, D., Trombetta, J.J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al., 2016. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189-196.

Van Allen, E.M., Miao, D., Schilling, B., Shukla, S.A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Foppen, M.H.G., Goldinger, S.M., et al., 2015. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207-211.

Yan, Y., Leontovich, A.A., Gerdes, M.J., Desai, K., Dong, J., Sood, A., SantamariaPang, A., Mansfield, A.S., Chadwick, C., Zhang, R., et al., 2019. Understanding heterogeneous tumor microenvironment in metastatic melanoma. PLoS One 14, e0216485.

Zhang, Y., Kurupati, R., Liu, L., Zhou, X.Y., Zhang, G., Hudaihed, A., Filisio, F., GilesDavis, W., Xu, X., Karakousis, G.C., et al., 2017. Enhancing CD8⁺ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Canc. Cell 32, 377-391. e9.

Zhang, P., Xiong, X., Rolfo, C., Du, X., Zhang, Y., Yang, H., Russo, A., Devenport, M., Zhou, P., Liu, Y., et al., 2020. Mechanism-and immune landscape-based ranking of therapeutic responsiveness of 22 major human cancers to next generation antiCTLA-4 antibodies. Cancers 12, 284.

Relative Articles

Supplements(0)

Cited By

Proportional views